AKT1 and neoplasm: The random forest model predicts that cinnamic acid has significant anti-tumor activity (probability = 0.69), which inhibits Hep3B cell proliferation (IC50 = 33.70 μM) and migration by targeting the PI3K/AKT signaling pathway (core targets PIK3R1, AKT1).